Cargando…

Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3

Despite the importance of Ras oncogenes as a therapeutic target in human cancer, their ‘undruggable’ tertiary structures limit the effectiveness of anti-Ras drugs. Canonical Wnt signaling contributes to Ras activity by glycogen synthase kinase 3 (GSK-3)-dependent phosphorylation at the C-terminus an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Sung Yong, Yang, Ji Hye, Kim, Nam Hee, Lee, Kyungro, Cha, Yong Hoon, Yun, Jun Seop, Kang, Hee Eun, Lee, Yoonmi, Choi, Jiwon, Kim, Hyun Sil, Yook, Jong In
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458253/ https://www.ncbi.nlm.nih.gov/pubmed/28418865 http://dx.doi.org/10.18632/oncotarget.16255

Ejemplares similares

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction
por: Ahn, Sung Yong, et al.
Publicado: (2017)

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
por: Kang, Hee Eun, et al.
Publicado: (2021)

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
por: Shin, Seung-Min, et al.
Publicado: (2020)

Dishevelling Wnt and Hippo
por: Kim, Nam Hee, et al.
Publicado: (2018)

Niclosamide Inhibits Aortic Valve Interstitial Cell Calcification by Interfering with the GSK-3β/β-Catenin Signaling Pathway
por: Adhikari, Radhika, et al.
Publicado: (2023)

Exploring the chemical space of protein–protein interaction inhibitors through machine learning
por: Choi, Jiwon, et al.
Publicado: (2021)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Ubiquitination-dependent, proteasomal degradation of the retroviral oncoprotein Tax by niclosamide, an anti-helminthic molecule
por: Xiang, Di, et al.
Publicado: (2014)

Prediction of African Swine Fever Virus Inhibitors by Molecular Docking-Driven Machine Learning Models
por: Choi, Jiwon, et al.
Publicado: (2021)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Involvement of Autophagy in Oncogenic K-Ras-induced Malignant Cell Transformation
por: Kim, Min-Jung, et al.
Publicado: (2011)

Hair follicle regeneration suppresses Ras-driven oncogenic growth
por: Pineda, Cristiana M., et al.
Publicado: (2019)

BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila
por: Doggett, Karen, et al.
Publicado: (2015)

Akt-mediated Ephexin1–Ras interaction promotes oncogenic Ras signaling and colorectal and lung cancer cell proliferation
por: Kim, Jeeho, et al.
Publicado: (2021)

Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner
por: Lee, Yoonmi, et al.
Publicado: (2018)

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
por: Yi, Young, et al.
Publicado: (2021)

The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy
por: Cho, Eunae Sandra, et al.
Publicado: (2018)

Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
por: Kaushal, Jyoti B., et al.
Publicado: (2021)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
por: Catalano, Antonella, et al.
Publicado: (2021)

Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression
por: Yang, Ji Hye, et al.
Publicado: (2020)

Niclosamide inhibits leaf blight caused by Xanthomonas oryzae in rice
por: Kim, Sung-Il, et al.
Publicado: (2016)

Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy
por: Kim, Hyun-Jun, et al.
Publicado: (2021)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress
por: Kim, Nam Hee, et al.
Publicado: (2017)

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
por: Wu, Y, et al.
Publicado: (2000)

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
por: Lock, Rebecca, et al.
Publicado: (2011)

Requirement for c-ras proteins during viral oncogene transformation
por: Smith, Mark R., et al.
Publicado: (1986)

Establishment and Characterization of Immortalized Miniature Pig Pancreatic Cell Lines Expressing Oncogenic K-Ras(G12D)
por: Yang, Hae-Jun, et al.
Publicado: (2020)

Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022)

Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras
por: Lee, Tae Hoon, et al.
Publicado: (2016)

A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab
por: Lee, Sang-Kyu, et al.
Publicado: (2018)

ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis
por: Kwon, Ok-Seon, et al.
Publicado: (2020)

Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
por: Huang, Xiaoling, et al.
Publicado: (2023)

Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
por: Khanim, F L, et al.
Publicado: (2011)

Migration and Transformation Characteristics of Niclosamide in a Soil–Plant System
por: Luo, Cui, et al.
Publicado: (2018)

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer
por: Kim, Nam Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0dtpnm7orv5sjd5fqpjcuqq5bb